Us Bancorp \De\ Iveric Bio, Inc. Transaction History

Us Bancorp \De\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$26.24 - $39.63 $1,548 - $2,338	-59 Reduced 7.29%	750 $29,000
Q1 2023 May 09, 2023	SELL	$18.67 - $24.56 $17,979 - $23,651	-963 Reduced 54.35%	809 $19,000
Q4 2022 Feb 13, 2023	SELL	$17.24 - $23.95 $408,122 - $566,968	-23,673 Reduced 93.04%	1,772 $37,000
Q3 2022 Oct 27, 2022	BUY	$9.4 - $18.59 $237,650 - $469,992	25,282 Added 15510.43%	25,445 $457,000
Q2 2022 Aug 01, 2022	SELL	$9.12 - $18.9 $8,490 - $17,595	-931 Reduced 85.1%	163 $2,000
Q1 2022 May 11, 2022	BUY	$12.15 - $16.83 $947 - $1,312	78 Added 7.68%	1,094 $18,000
Q3 2021 Nov 10, 2021	BUY	$7.07 - $17.5 $1,802 - $4,462	255 Added 33.51%	1,016 $17,000
Q2 2021 Aug 05, 2021	BUY	$5.69 - $7.17 $4,079 - $5,140	717 Added 1629.55%	761 $5,000
Q1 2021 Apr 28, 2021	BUY	$5.08 - $6.89 $223 - $303	44 New	44 $0

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.